Cargando…
MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin
The development of chemotherapy resistance significantly impairs the efficiency of chemotherapy, but the underlying mechanisms of chemotherapy resistance in gastric cancer (GC) are complicated and still need to be further explored. Here, we aimed to reveal the effects of miR-4290/PDK1 (pyruvate dehy...
Autores principales: | Qian, Yan, Wu, Xu, Wang, Haixiao, Hou, Guowei, Han, Xiao, Song, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184963/ https://www.ncbi.nlm.nih.gov/pubmed/32321153 http://dx.doi.org/10.1590/1414-431X20209330 |
Ejemplares similares
-
Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism
por: Subramaniam, Sugarniya, et al.
Publicado: (2021) -
MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
por: Li, Zheng, et al.
Publicado: (2016) -
4290 Acoustic screening for the “wet voice” in a canine laryngeal model
por: Rameau, Anais
Publicado: (2020) -
PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
por: Pai, Shin, et al.
Publicado: (2021) -
N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4
por: Li, Zihan, et al.
Publicado: (2020)